Cochrane
Easing sales in October were not enough to offset earlier gains, as year-to-date sales remained nearly four per cent higher than 2025 levels. The 62 sales in October were met with 142 new listings, keeping the sales-to-new-listings ratio relatively low at 44 per cent. This caused inventories to rise at a time when inventories typically decline. Higher inventory levels compared to sales caused the months of supply to approach six months for the first time since early 2020. The increase in supply was partly due to a rising share of new homes being listed on the resale market in October. The benchmark price was $571,100, down from September and nearly two per cent lower than October 2025 and on a year-to-date basis.
#cochrane #cochranehomesales #cochranelatestsales #calgarydreamhomes #luxuryhomes #stewartjlowe